Adverse events596

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 596

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anemia	Blood and lymphatic system disorders	Arm A1 (Regorafenib Dose Escalation + Pre-emptive Strategy)	4	28	5
other	Anemia	Blood and lymphatic system disorders	Arm A2 (Regorafenib Dose Escalation + Reactive Strategy)	8	26	15
other	Anemia	Blood and lymphatic system disorders	Arm B1 (Regorafenib Standard Dose + Pre-emptive Strategy)	7	33	10
other	Anemia	Blood and lymphatic system disorders	Arm B2 (Regorafenib Standard Dose + Reactive Strategy)	6	30	8
other	Blood and lymphatic system disorders - Other, specify	Blood and lymphatic system disorders	Arm A1 (Regorafenib Dose Escalation + Pre-emptive Strategy)	0	28	0
other	Blood and lymphatic system disorders - Other, specify	Blood and lymphatic system disorders	Arm A2 (Regorafenib Dose Escalation + Reactive Strategy)	0	26	0
other	Blood and lymphatic system disorders - Other, specify	Blood and lymphatic system disorders	Arm B1 (Regorafenib Standard Dose + Pre-emptive Strategy)	0	33	0
other	Blood and lymphatic system disorders - Other, specify	Blood and lymphatic system disorders	Arm B2 (Regorafenib Standard Dose + Reactive Strategy)	2	30	3
other	Thrombotic thrombocytopenic purpura	Blood and lymphatic system disorders	Arm A1 (Regorafenib Dose Escalation + Pre-emptive Strategy)	0	28	0
other	Thrombotic thrombocytopenic purpura	Blood and lymphatic system disorders	Arm A2 (Regorafenib Dose Escalation + Reactive Strategy)	1	26	5
other	Thrombotic thrombocytopenic purpura	Blood and lymphatic system disorders	Arm B1 (Regorafenib Standard Dose + Pre-emptive Strategy)	0	33	0
other	Thrombotic thrombocytopenic purpura	Blood and lymphatic system disorders	Arm B2 (Regorafenib Standard Dose + Reactive Strategy)	0	30	0
other	Sinus tachycardia	Cardiac disorders	Arm A1 (Regorafenib Dose Escalation + Pre-emptive Strategy)	0	28	0
other	Sinus tachycardia	Cardiac disorders	Arm A2 (Regorafenib Dose Escalation + Reactive Strategy)	0	26	0
other	Sinus tachycardia	Cardiac disorders	Arm B1 (Regorafenib Standard Dose + Pre-emptive Strategy)	1	33	1
other	Sinus tachycardia	Cardiac disorders	Arm B2 (Regorafenib Standard Dose + Reactive Strategy)	1	30	1
other	Tinnitus	Ear and labyrinth disorders	Arm A1 (Regorafenib Dose Escalation + Pre-emptive Strategy)	0	28	0
other	Tinnitus	Ear and labyrinth disorders	Arm A2 (Regorafenib Dose Escalation + Reactive Strategy)	0	26	0
other	Tinnitus	Ear and labyrinth disorders	Arm B1 (Regorafenib Standard Dose + Pre-emptive Strategy)	1	33	2
other	Tinnitus	Ear and labyrinth disorders	Arm B2 (Regorafenib Standard Dose + Reactive Strategy)	0	30	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02368886/events

API reference For AI assistants

Adverse events596

Sources 3

Read this list from software.